Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patientsEnric Carreras, Laura Rosiñol, Maria José Terol, et al.Leukemia & Lymphoma|April 11, 2015
Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancyNicholas Kelleher, David Gallardo, José González-Campos, et al.Oncotarget|August 4, 2016
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresLaura Palomo, Olga Garcia, Montse Arnan, et al.British Journal of Haematology|September 22, 2021
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades, et al.Medicina Clinica|September 3, 2005
[Prevalence and prognostic significance of myeloid markers in adults with high-risk acute lymphoblastic leukemia]Esther Plensa, Josep Maria Ribera, Albert Oriol, et al.Haematologica|February 11, 2010
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study GroupAlbert Oriol, Susana Vives, Jesús-María Hernández-Rivas, et al.European Journal of Haematology|June 10, 2010
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab eraJuan-Manuel Sancho, Alberto Orfao, Sandra Quijano, et al.Blood|February 5, 2013
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapyMarta Pratcorona, Salut Brunet, Josep Nomdedéu, et al.Genes, Chromosomes & Cancer|August 1, 2017
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanismsJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.Cancer|July 22, 2015
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocolsJordi Ribera, Mireia Morgades, Lurdes Zamora, et al.Pageof 20